SintonJA.Studies in malaria, with special reference to treatment. Part II. The effects of treatment on the prevention of relapse in infections with Plasmodium falciparum. Indian J Med Res1926;
13: 579–601.
4.
MartiniP.Methodenlehre der Therapeutischen Untersuchung [Methodological Principles for Therapeutic Investigations].
Berlin:
Springer, 1932.
5.
HillAB.Principles of Medical Statistics.
London:
Lancet, 1937.
6.
GaddumJH.Therapeutic trials on man. In: GaddumJH, ed. Pharmacology.
London:
Oxford University Press, 1940: 379–383.
7.
BellJA.Pertussis prophylaxis with two doses of alum-precipitated vaccine. Public Health Rep1941;
56: 1535–1546.
8.
Medical Research Council.
Clinical trial of patulin in the common cold. Lancet1944;
2:373–375.
MainlandD.Intercurrent events. In: Elementary Medical Statistics: The Principles of Quantitative Medicine.
London:
WB Saunders Company, 1952: 109.
11.
Medical Research Council. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. Br Med J 1948; 2: 769–782.
12.
ArmitageP.The construction of comparable groups. In: HillAB, ed. Controlled Clinical Trials.
Oxford:
Blackwell, 1960: 14–18.
13.
ChalmersI.Statistical theory was not the reason that randomisation was used in the British Medical Research Council’s clinical trial of streptomycin for pulmonary tuberculosis. In: JorlandGOpinelAWeiszG, eds. Body Counts: Medical Quantification in Historical and Sociological Perspectives.
Montreal:
McGill-Queens University Press, 2005: 309–334.
14.
DollR.The role of data monitoring committees. In: DuleyLFarrellB, eds. Clinical Trials.
London:
BMJ Books, 2002: 97–104.
Mainland D. Elementary Medical Statistics: the Principles of Quantitative Medicine. India: Pranava Books, 1952.
26.
MainlandD.Lost information. In: Elementary Medical Statistics: The Principles of Quantitative Medicine.
London:
WB Saunders Company, 1963: 178–186.
27.
ShapiroAKShapiroE.The Powerful Placebo: From Ancient Priest to Modern Physician.
Baltimore:
Johns Hopkins University Press, 1997.
28.
BernsteinLWeatherallM.Statistics for Medical and other Biological Students.
London:
E & S Livingstone, 1952.
29.
HerdanG.Statistics of Therapeutic Trials.
London:
Elsevier, 1955.
30.
WhitelockOVFurnessFNCraverBN, eds. Experimental methods for the evaluation of drugs in various disease states. Ann N Y Acad Sci1956;
64: 463–731.
31.
GoldH.Experiences in human pharmacology. In: LaurenceDR, ed. Quantitative Methods in Human Pharmacology and Therapeutics.
London:
Pergamon Press, 1959: 40–54.
32.
StamlerJPickRKatzLN.Experiences in assessing estrogen antiatherogenesis in the chick, the rabbit, and man. Ann NY Acad Sci1956;
64: 596–619.
33.
SutherlandI. Statistical aspects of clinical trials. In: Dodds C, ed. Report of a Symposium on Clinical Trials held at The Royal Society of Medicine, London, 25 April, 1958:53; 50–55.
34.
WaifeSOShapiroAP.The Clinical Evaluation of New Drugs.
New York:
Hoeber-Harper, 1959.
35.
LasagnaLMeierP.Experimental design and statistical problems. In: WaifeSOShapiroAP, eds. The Clinical Evaluation of New Drugs.
New York:
Hoeber, 1959: 37–60.
36.
LaurenceDR, ed. Quantitative Methods in Human Pharmacology and Therapeutics.
London:
Pergamon Press, 1959.
37.
DollR.Practical problems of drug trials in clinical practice. In: LaurenceDR, ed. Quantitative Methods in Human Pharmacology and Therapeutics.
London:
Pergamon Press, 1959: 213–221.
38.
WittsLJ, ed. Medical Surveys and Clinical Trials.
London:
Oxford University Press, 1959.
39.
KnoweldenJ.Prophylactic trials. In: WittsLJ, ed. Medical Surveys and Clinical Trials.
London:
Oxford University Press, 1959: 118–133.
